![]() | Up a level |
Ivaskevicius, Vytautas; Biswas, Arijit; Bevans, Carville; Schroeder, Verena; Kohler, Hans Peter; Rott, Hannelore; Halimeh, Susan; Petrides, Petro E; Lenk, Harald; Krause, Manuele; Miterski, Bruno; Harbrecht, Ursula; Oldenburg, Johannes (2010). Identification of eight novel coagulation factor XIII subunit A mutations: implied consequences for structure and function. Haematologica - the hematology journal, 95(6), pp. 956-962. Pavia: Ferrata-Storti Foundation 10.3324/haematol.2009.017210
Giers, Günther; Wenzel, Folker; Stockschläder, Markus; Riethmacher, Regina; Lorenz, Horst; Tutschek, Boris (2010). Fetal alloimmune thrombocytopenia and maternal intravenous immunoglobulin infusion. Haematologica - the hematology journal, 95(11), pp. 1921-6. Pavia: Ferrata-Storti Foundation 10.3324/haematol.2010.025106
Froehlich-Zahnd, Rahel; George, James N; Vesely, Sara K; Terrell, Deirdra R; Aboulfatova, Khatira; Dong, Jing-Fei; Luken, Brenda M; Voorberg, Jan; Budde, Ulrich; Sulzer, Irmela; Lämmle, Bernhard; Kremer Hovinga, Johanna A (2011). Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura. Haematologica - the hematology journal, 97(2), pp. 297-303. Pavia: Ferrata-Storti Foundation
Nellen, Vanessa; Sulzer, Irmela; Barizzi, Gabriela; Lämmle, Bernhard; Alberio, Lorenzo (2011). Rapid exclusion or confirmation of heparin-induced thrombocytopenia: a single-center experience with 1,291 patients. Haematologica - the hematology journal, 97(1), pp. 89-97. Pavia: Ferrata-Storti Foundation 10.3324/haematol.2011.048074
Alter, Blanche P; Rosenberg, Philip S; Giri, Neelam; Baerlocher, Gabriela M; Lansdorp, Peter M; Savage, Sharon A (2012). Telomere length is associated with disease severity and declines with age in dyskeratosis congenita. Haematologica - the hematology journal, 97(3), pp. 353-9. Pavia: Ferrata-Storti Foundation 10.3324/haematol.2011.055269
Skiada, Anna; Lanternier, Fanny; Groll, Andreas H; Pagano, Livio; Zimmerli, Stefan; Herbrecht, Raoul; Lortholary, Olivier; Petrikkos, George L; European Conference on Infections in Leukemia, (2013). Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3). Haematologica - the hematology journal, 98(4), pp. 492-504. Pavia: Ferrata-Storti Foundation 10.3324/haematol.2012.065110
Oppliger Leibundgut, Elisabeth; Horn, Michael Peter; Brunold, Claudio; Pfanner-Meyer, Brigitte; Marti, Dorothee; Hirsiger, Hans; Tobler, Andreas; Zwicky, Caroline (2006). Hematopoietic and endothelial progenitor cell trafficking in patients with myeloproliferative diseases. Haematologica - the hematology journal, 91(11), pp. 1465-72. Pavia: Ferrata-Storti Foundation
Zimmermann, A (2006). Histopathologic and biologic aspects of hepatoblastoma. Haematologica - the hematology journal, 91(Suppl 4), pp. 28-29. Pavia: Ferrata-Storti Foundation
Aydinok, Yesim; Ulger, Zulal; Nart, Deniz; Terzi, Aysen; Cetiner, Nurten; Ellis, Gareth; Zimmermann, Arthur; Manz, Chantal (2007). A randomized controlled 1-year study of daily deferiprone plus twice weekly desferrioxamine compared with daily deferiprone monotherapy in patients with thalassemia major. Haematologica - the hematology journal, 92(12), pp. 1599-606. Pavia: Ferrata-Storti Foundation 10.3324/haematol.11414
Swisher, Karen K; Doan, John T; Vesely, Sara K; Kwaan, Hau C; Kim, Benjamin; Laemmle, Bernhard; Kremer Hovinga, Johanna A; George, James N (2007). Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports. Haematologica - the hematology journal, 92(7), pp. 936-43. Pavia: Ferrata-Storti Foundation 10.3324/haematol.10963
Ruutu, T; Barosi, G; Benjamin, RJ; Clark, RE; George, JN; Gratwohl, A; Holler, E; Iacobelli, M; Kentouche, K; Lämmle, B; Moake, JL; Richardson, P; Socié, G; Zeigler, Z; Niederwieser, D; Barbui, T; European, Group for Blood; Marrow, Transplantation; European, LeukemiaNet (2007). Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. Haematologica - the hematology journal, 92(1), pp. 95-100. Pavia: Ferrata-Storti Foundation 10.3324/haematol.10699
Lämmle, Bernhard; Kremer Hovinga, Johanna A; George, James N (2008). Acquired thrombotic thrombocytopenic purpura: ADAMTS13 activity, anti-ADAMTS13 autoantibodies and risk of recurrent disease. Haematologica - the hematology journal, 93(2), pp. 172-7. Pavia: Ferrata-Storti Foundation 10.3324/haemato.12701
Pathak, Anand; Seipel, Katja; Pemov, Alexander; Dewan, Ramita; Brown, Christina; Ravichandran, Sarangan; Luke, Brian T; Malasky, Michael; Suman, Shalabh; Yeager, Meredith; Cancer GenomicsResearch Laboratory, Nci Dceg; Cancer Sequencing Working Group, Nci Dceg; Parry, Dilys M; Gatti, Richard A; Caporaso, Neil E; Mulvihill, John; Goldin, Lynn R; Pabst, Thomas; McMaster, Mary L and Stewart, Douglas R (2016). Whole-exome sequencing reveals a C-terminal germline variant in CEBPA-associated acute myeloid leukemia: 45-year follow-up of a large family. Haematologica - the hematology journal, 101(7), pp. 846-852. Ferrata-Storti Foundation 10.3324/haematol.2015.130799
Driessen, Christoph; Kraus, Marianne; Joerger, Markus; Rosing, Hilde; Bader, Jürgen; Hitz, Felicitas; Berset, Catherine; Xyrafas, Alexandros; Hawle, Hanne; Berthod, Gregoire; Overkleeft, Hermann S; Sessa, Cristiana; Huitema, Alwin; Pabst, Thomas; von Moos, Roger; Hess, Dagmar; Mey, Ulrich J M (2016). Treatment with the HIV protease inhibitor Nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08). Haematologica - the hematology journal, 101(3), pp. 346-355. Ferrata-Storti Foundation 10.3324/haematol.2015.135780
Walter, Roland B; Othus, Megan; Löwenberg, Bob; Ossenkoppele, Gert J; Petersdorf, Stephen H; Pabst, Thomas; Vekemans, Marie-Christiane; Appelbaum, Frederick R; Erba, Harry P; Estey, Elihu H (2015). Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG. Haematologica - the hematology journal, 100(10), e409-e411. Ferrata-Storti Foundation 10.3324/haematol.2015.130013
Trabanelli, Sara; Curti, Antonio; Lecciso, Mariangela; Salomé, Bérengère; Riether, Carsten; Ochsenbein, Adrian; Romero, Pedro; Jandus, Camilla (2015). CD127+ innate lymphoid cells are dysregulated in treatment naïve acute myeloid leukemia patients at diagnosis. Haematologica - the hematology journal, 100(7), e257-e260. Ferrata-Storti Foundation 10.3324/haematol.2014.119602
Stathis, Anastasios; Pirosa, Maria Cristina; Orsucci, Lorella; Feugier, Pierre; Tani, Monica; Ghesquières, Hervé; Musuraca, Gerardo; Rossi, Francesca Gaia; Merli, Francesco; Guièze, Romain; Gyan, Emmanuel; Gini, Guido; Marino, Dario; Gressin, Remy; Morschhauser, Franck; Cavallo, Federica; Palombi, Francesca; Conconi, Annarita; Tessoulin, Benoît; Tilly, Hervé; ... (2024). IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma. Haematologica - the hematology journal, 109(8), pp. 2564-2573. Ferrata-Storti Foundation 10.3324/haematol.2023.283918
Herbst, Christine; Rehan, Fareed A; Brillant, Corinne; Bohlius, Julia; Skoetz, Nicole; Schulz, Holger; Monsef, Ina; Specht, Lena; Engert, Andreas (2010). Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin's lymphoma: a systematic review. Haematologica - the hematology journal, 95(3), pp. 494-500. Pavia: Ferrata-Storti Foundation 10.3324/haematol.2009.015644
Ferrari, Silvia; Palavra, Kristina; Gruber, Bernadette; Kremer Hovinga, Johanna Anna; Knöbl, Paul; Caron, Claudine; Cromwell, Caroline; Aledort, Louis; Plaimauer, Barbara; Turecek, Peter L.; Rottensteiner, Hanspeter; Scheiflinger, Friedrich (2014). Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura. Haematologica - the hematology journal, 99(4), pp. 779-787. Ferrata-Storti Foundation 10.3324/haematol.2013.094151
Nagy, Magdolna; Mastenbroek, Tom G; Mattheij, Nadine J A; de Witt, Susanne; Clemetson, Kenneth John; Kirschner, Janbernd; Schulz, Ansgar S; Vraetz, Thomas; Speckmann, Carsten; Braun, Attila; Cosemans, Judith M E M; Zieger, Barbara; Heemskerk, Johan W M (2018). Variable impairment of platelet functions in patients with severe, genetically linked immune deficiencies. Haematologica - the hematology journal, 103(3), pp. 540-549. Ferrata-Storti Foundation 10.3324/haematol.2017.176974
Seipel, Katja; Marques, Miguel A T; Sidler, Corinne; Mueller, Beatrice U; Pabst Müller, Thomas Niklaus (2018). MDM2- and FLT3-inhibitors in the treatment of -ITD acute myeloid leukemia, specificity and efficacy of NVP-HDM201 and midostaurin. Haematologica - the hematology journal, 103(11), pp. 1862-1872. Ferrata-Storti Foundation 10.3324/haematol.2018.191650
Brenig, Bertram; Steingräber, Lilith; Shan, Shuwen; Xu, Fangzheng; Hirschfeld, Marc; Andag, Reiner; Spengeler, M; Dietschi, Elisabeth; Mischke, Reinhard; Leeb, Tosso (2019). Christmas disease in a Hovawart family resembling human hemophilia B Leyden is caused by a single nucleotide deletion in a highly conserved transcription factor binding site of the F9 gene promoter. Haematologica - the hematology journal, 104(11), pp. 2307-2313. Ferrata-Storti Foundation 10.3324/haematol.2018.215426
Burkhard, Regula; Keller, Irene; Arambasic, Miroslav; Juskevicius, Darius; Tzankov, Alexandar; Lundberg, Pontus; Bruggmann, Rémy; Dirnhofer, Stephan; Radpour, Ramin; Novak, Urban (2019). TIRAP p.R81C is a novel lymphoma risk variant which enhances cell proliferation via NF-κB mediated signaling in B-cells. Haematologica - the hematology journal, 104(4), pp. 766-777. Ferrata-Storti Foundation 10.3324/haematol.2018.201590
Berger, Martin D.; Trelle, Sven; Büchi, Annina E.; Jegerlehner, Sabrina; Ionescu, Codruta; Lamy de la Chapelle, Thierry; Novak, Urban (2021). Impact on survival through consolidation radiotherapy for diffuse large B-cell lymphoma: a comprehensive meta-analysis. Haematologica - the hematology journal, 106(7), pp. 1923-1931. Ferrata-Storti Foundation 10.3324/haematol.2020.249680
Tettero, Jesse M; Ngai, Lok Lam; Bachas, Costa; Breems, Dimitri A; Fischer, Thomas; Gjertsen, Bjorn T; Gradowska, Patrycja; Griskevicius, Laimonas; Janssen, Jeroen J W M; Juliusson, Gunnar; Maertens, Johan; Manz, Markus G; Pabst, Thomas; Passweg, Jakob; Porkka, Kimmo; Valk, Peter J M; Löwenberg, Bob; Ossenkoppele, Gert J; Cloos, Jacqueline (2023). Measurable residual disease-guided therapy in intermediate-risk acute myeloid leukemia patients is a valuable strategy in reducing allogeneic transplantation without negatively affecting survival. Haematologica - the hematology journal, 108(10), pp. 2794-2798. Ferrata-Storti Foundation 10.3324/haematol.2022.282639
Stivala, Simona; Gobbato, Sara; Infanti, Laura; Reiner, Martin F; Bonetti, Nicole; Meyer, Sara C.; Camici, Giovanni G; Lüscher, Thomas F; Buser, Andreas; Beer, Jürg H (2017). Amotosalen/ultraviolet A pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance. Haematologica - the hematology journal, 102(10), pp. 1650-1660. Ferrata-Storti Foundation 10.3324/haematol.2017.164137
Hanfstein, Benjamin; Lauseker, Michael; Hehlmann, Rüdiger; Saussele, Susanne; Erben, Philipp; Dietz, Christian; Fabarius, Alice; Proetel, Ulrike; Schnittger, Susanne; Haferlach, Claudia; Krause, Stefan W; Schubert, Jörg; Einsele, Hermann; Hänel, Mathias; Dengler, Jolanta; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; Kneba, Michael; Stegelmann, Frank; ... (2014). Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib. Haematologica - the hematology journal, 99(9), pp. 1441-1447. Ferrata-Storti Foundation 10.3324/haematol.2013.096537
Engert, A.; Balduini, C.; Brand, A.; Coiffier, B.; Cordonnier, C.; Dohner, H.; de Wit, T. D.; Eichinger, S.; Fibbe, W.; Green, T.; de Haas, F.; Iolascon, A.; Jaffredo, T.; Rodeghiero, F.; Salles, G.; Schuringa, J. J.; EHA, Roadmap for European Hematology Research (2016). The European Hematology Association Roadmap for European Hematology Research: a consensus document. Haematologica - the hematology journal, 101(2), pp. 115-208. Ferrata-Storti Foundation 10.3324/haematol.2015.136739
Wartenberg, Martin; Vasil, Peter; zum Bueschenfelde, Christian Meyer; Ott, German; Rosenwald, Andreas; Fend, Falko; Kremer, Marcus (2013). Somatic hypermutation analysis in follicular lymphoma provides evidence suggesting bidirectional cell migration between lymph node and bone marrow during disease progression and relapse. Haematologica - the hematology journal, 98(9), pp. 1433-1441. Ferrata-Storti Foundation 10.3324/haematol.2012.074252
Schlenk, Richard F; Krauter, Jürgen; Raffoux, Emmanuel; Kreuzer, Karl-Anton; Schaich, Markus; Noens, Lucien; Pabst, Thomas; Vusirikala, Madhuri; Bouscary, Didier; Spencer, Andrew; Candoni, Anna; Gil, Jorge Sierra; Berkowitz, Noah; Weber, Hans-Jochen; Ottmann, Oliver (2018). Panobinostat monotherapy and combination therapy in patients with acute myeloid leukemia: results from two clinical trials. Haematologica - the hematology journal, 103(1), e25-e28. Ferrata-Storti Foundation 10.3324/haematol.2017.172411
Bacher, Vera Ulrike; Porret, Naomi; Joncourt, Raphael; Sanz, Javier; Aliu, Nijas; Wiedemann, Gertrud; Jeker, Barbara; Banz Wälti, Yara; Pabst, Thomas (2018). Pitfalls in the molecular follow up of mutant acute myeloid leukemia. Haematologica - the hematology journal, 103(10), e486-e488. Ferrata-Storti Foundation 10.3324/haematol.2018.192104
Rijkers, Maaike; Schmidt, David; Lu, Nina; Kramer, Cynthia S M; Heidt, Sebastiaan; Mulder, Arend; Porcelijn, Leendert; Claas, Frans H J; Leebeek, Frank W G; Jansen, A J Gerard; Jongerius, Ilse; Zeerleder, Sacha S; Vidarsson, Gestur; Voorberg, Jan; de Haas, Masja (2019). Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets. Haematologica - the hematology journal, 104(2), pp. 403-416. Ferrata-Storti Foundation 10.3324/haematol.2018.201665
Michel, Christian; Burchert, Andreas; Hochhaus, Andreas; Saussele, Susanne; Neubauer, Andreas; Lauseker, Michael; Krause, Stefan W; Kolb, Hans-Jochem; Hossfeld, Dieter Kurt; Nerl, Christoph; Baerlocher, Gabriela M.; Heim, Dominik; Brümmendorf, Tim H; Fabarius, Alice; Haferlach, Claudia; Schlegelberger, Brigitte; Balleisen, Leopold; Goebeler, Maria-Elisabeth; Hänel, Mathias; Ho, Anthony; ... (2019). Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV. Haematologica - the hematology journal, 104(5), pp. 955-962. Ferrata-Storti Foundation 10.3324/haematol.2018.206797
van Dorland, Hendrika Anette; Mansouri Taleghani, Magnus; Sakai, Kazuya; Friedman, Kenneth D; George, James N; Hrachovinova, Ingrid; Knöbl, Paul N; von Krogh, Anne Sophie; Schneppenheim, Reinhard; Aebi-Huber, Isabella; Bütikofer, Lukas; Largiadèr, Carlo R.; Cermakova, Zuzana; Kokame, Koichi; Miyata, Toshiyuki; Yagi, Hideo; Terrell, Deirdra R; Vesely, Sara K; Matsumoto, Masanori; Lämmle, Bernhard; ... (2019). The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: Key findings at enrolment until 2017. Haematologica - the hematology journal, 104(10), pp. 2107-2115. Ferrata-Storti Foundation 10.3324/haematol.2019.216796
De Santiago de Benito, Alvaro; Jeker, Barbara; Gfeller, Eva; Porret, Naomi; Banz, Yara; Novak, Urban; Bacher, Ulrike; Pabst, Thomas (2020). Molecular minimal residual disease negativity and decreased stem cell mobilization potential predict excellent outcome after autologous transplant in NPM1 mutant acute myeloid leukemia. Haematologica - the hematology journal, 105(1), e9-e12. Ferrata-Storti Foundation 10.3324/haematol.2019.216457
Baas, Inge; Delvasto-Nuñez, Laura; Ligthart, Peter; Brouwer, Conny; Folman, Claudia; Reis, Edimara S; Ricklin, Daniel; Lambris, John D; Wouters, Diana; de Haas, Masja; Jongerius, Ilse; Zeerleder, Sacha S. (2020). Complement C3 inhibition by compstatin Cp40 prevents intra- and extravascular hemolysis of red blood cells. Haematologica - the hematology journal, 105(2), e57-e60. Ferrata-Storti Foundation 10.3324/haematol.2019.216028
Lazaryan, Aleksandr; Dolan, Michelle; Zhang, Mei-Jie; Wang, Hai-Lin; Kharfan-Dabaja, Mohamed A; Marks, David I; Bejanyan, Nelli; Copelan, Edward; Maijhail, Navneet; Waller, Edmund K; Chao, Nelson; Prestidge, Tim; Nishihori, Taiga; Kebriaei, Partow; Inamoto, Yoshihiro; Hamilton, Betty; Hashmi, Shahrukh K; Kamble, Rammurti T; Bacher, Ulrike; Hildebrandt, Gerhard C; ... (2020). Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research. Haematologica - the hematology journal, 105(5), pp. 1329-1338. Ferrata-Storti Foundation 10.3324/haematol.2019.220756
Tichelli, André; Peffault de Latour, Régis; Passweg, Jakob; Knol-Bout, Cora; Socié, Gérard; Marsh, Judith; Schrezenmeier, Hubert; Höchsmann, Britta; Bacigalupo, Andrea; Samarasinghe, Sujith; Rovó, Alicia; Kulasekararaj, Austin; Röth, Alexander; Eikema, Dirk-Jan; Bosman, Paul; Bader, Peter; Risitano, Antonio; Dufour, Carlo (2020). Long-term outcome of a randomized controlled study in patients with newly diagnosed severe aplastic anemia treated with antithymocyte globuline, cyclosporine, with or without G-CSF: a Severe Aplastic Anemia Working Party Trial from the European Group of Blood and Marrow Transplantation. Haematologica - the hematology journal, 105(5), pp. 1223-1231. Ferrata-Storti Foundation 10.3324/haematol.2019.222562
Oppliger Leibundgut, Elisabeth; Brunold, Claudio; Marti, Dorothee; Horn, Michael Peter; Seiler, Christian; Schroeder, Verena; Schmid, Jean-Paul; Tobler, Andreas; Zwicky, Caroline (2005). Progenitor cell trafficking in physiologic conditions and in myeloproliferative diseases: quantification of CD34+ cells by polymerase chain reaction. Haematologica - the hematology journal, 90(7), pp. 875-880. Ferrata-Storti Foundation
Oppliger Leibundgut, Elisabeth; Haubitz, Monika; Burington, Bart; Ottmann, Oliver G; Spitzer, Gary; Odenike, Olatoyosi; McDevitt, Michael A; Röth, Alexander; Snyder, David S; Baerlocher, Gabriela M. (2021). Dynamics of mutations in patients with essential thrombocythemia treated with imetelstat. Haematologica - the hematology journal, 106(9), pp. 2397-2404. Ferrata-Storti Foundation 10.3324/haematol.2020.252817
Thorball, Christian W; Oudot-Mellakh, Tiphaine; Ehsan, Nava; Hammer, Christian; Santoni, Federico A; Niay, Jonathan; Costagliola, Dominique; Goujard, Cécile; Meyer, Laurence; Wang, Sophia S; Hussain, Shehnaz K; Theodorou, Ioannis; Cavassini, Matthias; Rauch, Andri; Battegay, Manuel; Hoffmann, Matthias; Schmid, Patrick; Bernasconi, Enos; Günthard, Huldrych F; Mohammadi, Pejman; ... (2021). Genetic variation near CXCL12 is associated with susceptibility to HIV-related non-Hodgkin lymphoma. Haematologica - the hematology journal, 106(8), pp. 2233-2241. Ferrata-Storti Foundation 10.3324/haematol.2020.247023
Lazaryan, Aleksandr; Dolan, Michelle; Zhang, Mei-Jie; Wang, Hai-Lin; Kharfan-Dabaja, Mohamed A; Marks, David I; Bejanyan, Nelli; Copelan, Edward; Majhail, Navneet S; Waller, Edmund K; Chao, Nelson; Prestidge, Tim; Nishihori, Taiga; Kebriaei, Partow; Inamoto, Yoshihiro; Hamilton, Betty; Hashmi, Shahrukh K; Kamble, Rammurti T; Bacher, Ulrike; Hildebrandt, Gerhard C; ... (2021). Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research. Haematologica - the hematology journal, 106(8), pp. 2295-2296. Ferrata-Storti Foundation 10.3324/haematol.2021.279046
Tichelli, André; Peffault De Latour, Régis; Dufour, Carlo; Rovó, Alicia (2022). Adding eltrombopag to immunosuppression: the importance of predicting outcome. Haematologica - the hematology journal, 107(1), pp. 46-48. Ferrata-Storti Foundation 10.3324/haematol.2021.278761
Corre, Tanguy; Ponte, Belen; Pivin, Edward; Pruijm, Menno; Ackermann, Daniel; Ehret, Georg; Spanaus, Katharina; Bochud, Murielle; Wenger, Roland H (2021). Heritability and association with distinct genetic loci of erythropoietin levels in the general population. Haematologica - the hematology journal, 106(9), pp. 2499-2501. Ferrata-Storti Foundation 10.3324/haematol.2021.278389
Mei, Matthew; Pillai, Raju; Kim, Soyoung; Estrada-Merly, Noel; Afkhami, Michelle; Yang, Lixin; Meng, Zhuo; Abid, Muhammad Bilal; Aljurf, Mahmoud; Bacher, Ulrike; Beitinjaneh, Amer; Bredeson, Christopher; Cahn, Jean-Yves; Cerny, Jan; Copelan, Edward; Cutler, Corey; DeFilipp, Zachariah; Diaz Perez, Miguel Angel; Farhadfar, Nosha; Freytes, César O; ... (2023). The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis. Haematologica - the hematology journal, 108(1), pp. 150-160. Ferrata-Storti Foundation 10.3324/haematol.2021.280203
Lämmle, Bernhard (2023). A third form of thrombotic thrombocytopenic purpura? Haematologica - the hematology journal, 108(2), pp. 299-300. Ferrata-Storti Foundation 10.3324/haematol.2022.281095
Rein, Avigail; Geron, Ifat; Kugler, Eitan; Fishman, Hila; Gottlieb, Eyal; Abramovich, Ifat; Giladi, Amir; Amit, Ido; Mulet-Lazaro, Roger; Delwel, Ruud; Gröschel, Stefan; Levin-Zaidman, Smadar; Dezorella, Nili; Holdengreber, Vered; Rao, Tata Nageswara; Yacobovich, Joanne; Steinberg-Shemer, Orna; Huang, Qiu-Hua; Tan, Yun; Chen, Sai-Juan; ... (2023). Cellular and metabolic characteristics of pre-leukemic hematopoietic progenitors with GATA2 haploinsuficiency. Haematologica - the hematology journal, 108(9), pp. 2316-2330. Ferrata-Storti Foundation 10.3324/haematol.2022.279437
Pabst, Thomas; Vey, Norbert; Adès, Lionel; Bacher, Ulrike; Bargetzi, Mario; Fung, Samson; Gaidano, Gianluca; Gandini, Domenica; Hultberg, Anna; Johnson, Amy; Ma, Xuewen; Müller, Rouven; Nottage, Kerri; Papayannidis, Cristina; Recher, Christian; Riether, Carsten; Shah, Priya; Tryon, Jeffrey; Xiu, Liang and Ochsenbein, Adrian F (2023). Results from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy. Haematologica - the hematology journal, 108(7), pp. 1793-1802. Ferrata-Storti Foundation 10.3324/haematol.2022.281563
Schmid, Jonas Andreas; Festl, Yasmin; Severin, Yannik; Bacher, Vera; Kronig, Marie-Noëlle; Snijder, Berend; Pabst, Thomas (2024). Efficacy and feasibility of pharmacoscopy-guided treatment for acute myeloid leukemia patients who have exhausted all registered therapeutic options. Haematologica - the hematology journal, 109(2), pp. 617-621. Ferrata-Storti Foundation 10.3324/haematol.2023.283224
Andersson, Nadine G; Labarque, Veerle; Kartal-Kaess, Mutlu; Pinto, Fernando; Mikkelsen, Torben Stamm; Ljung, Rolf; Group, PedNet Study (2024). Factor VIII genotype and the risk of developing high-responding or low-responding inhibitors in severe hemophilia A: data from the PedNet Hemophilia Cohort of 1,202 children. Haematologica, 109(4), pp. 1293-1296. Ferrata-Storti Foundation 10.3324/haematol.2023.284095
Stivala, Simona; Gobbato, Sara; Infanti, Laura; Reiner, Martin F; Bonetti, Nicole; Meyer, Sara C.; Camici, Giovanni G; Lüscher, Thomas F; Buser, Andreas; Beer, Juerg H (2017). In response to the comment by Hechler et al.: Amotosalen/UVA pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance. Haematologica - the hematology journal, 102(12), e504-e505. Ferrata-Storti Foundation 10.3324/haematol.2017.181818